A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| MMAE | Monomethyl Auristatin E (MMAE) is a synthetic analog of dolastatin 10 that similarly inhibits tubulin polymerization and exhibits potent cytotoxicity. It is commonly conjugated with monoclonal antibodies directed at antigens specific to cancer cells for tumor-directed cytotoxicity. Uses: Adcs cytotoxin. Alternative Names: MMAE; Vedotin; Monomethyl auristatin E; Monomethylauristatin E; N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide. Grades: ≥98.0% by HPLC. CAS No. 474645-27-7. Molecular formula: C39H67N5O7. Mole weight: 717.98. |  |
| MMAE-[13C5,15N] | MMAE-[13C5,15N] is a labelled analogue of MMAE, which is a potent mitotic inhibitor and a tubulin inhibitor. Alternative Names: [13C5,15N]-MMAE; [13C5,15N]-Monomethyl auristatin E; Monomethyl auristatin E-13C5,15N. Molecular formula: C34[13C]5H67N4[15]NO7. Mole weight: 723.95. | |
| MMAE-d8 | MMAE-d8 is a deuterated labeled MMAE, a potent mitotic inhibitor and a tubulin inhibitor. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Monomethyl auristatin E-d8; Deuterated labeled MMAE. CAS No. 2070009-72-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-15162A. |  |
| MMAE-[d8] | MMAE-[d8] is a labelled analogue of MMAE, which is a potent mitotic inhibitor and a tubulin inhibitor. Alternative Names: D8-MMAE; D8-Monomethyl auristatin E. Grades: 98% by HPLC; 98% atom D. CAS No. 2070009-72-0. Molecular formula: C39H59D8N5O7. Mole weight: 726.03. | |
| MMAE (Monomethyl auristatin E) | MMAE (Monomethyl auristatin E) is a synthetic antineoplastic agent. It is also a microtubule-disrupting agent. Group: Inhibitors. Alternative Names: SGD-1010. CAS No. 474645-27-7. Pack Sizes: 1mg. Product ID: S7721. Formula: C39H67N5O7. . Smiles: CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(C)C(C2=CC=CC=C2)O)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)NC. Storage Conditions: -20°C power 3 years. |  United States; Europe |
| MMAE-SMCC | MMAE-SMCC is a agent-linker conjugate for ADC. MMAE-SMCC is composed of a potent mitotic and a tubulin inhibitor MMAE and a linker SMCC to make antibody agent conjugate. Uses: Scientific research. Category: Signaling pathways. CAS No. 2021179-11-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-135660. | |
| MMAF | MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Monomethylauristatin F. CAS No. 745017-94-1. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg. Product ID: HY-15579. | |
| MMAF | Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody. Uses: Adcs cytotoxin. Alternative Names: Monomethylauristatin F; Monomethyl Auristatin F; N-Methyl-L-valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(αR,βR,2S)-β-methoxy-α-methyl-2-pyrrolidinepropanoyl-L-phenylalanine; Monomethylauristatin Phenylalanine; L-Valinamide, N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1S)-1-carboxy-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-; ((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoyl)-L-phenylalanine. Grades: ≥98% by HPLC. CAS No. 745017-94-1. Molecular formula: C39H65N5O8. Mole weight: 731.48. | |
| MMAF hydrochloride | MMAF (Monomethylauristatin F) hydrochloride is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF hydrochloride is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Monomethylauristatin F hydrochloride. CAS No. 1415246-68-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg. Product ID: HY-15579A. | |
| MMAF Hydrochloride | MMAF Hydrochloride, a synthetic antineoplastic agent, is a tubulin polymerization inhibitor that inhibits cell division by blocking the polymerization of tubulin. It is part of some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. Uses: Adcs cytotoxin. Alternative Names: Monomethylauristatin F Hydrochloride; Monomethyl Auristatin F Hydrochloride; N-Methyl-L-valyl-L-valyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(αR,βR,2S)-β-methoxy-α-methyl-2-pyrrolidinepropanoyl-L-phenylalanine Hydrochloride; Monomethylauristatin Phenylalanine Hydrochloride; L-Valinamide, N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1S)-1-carboxy-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-, Hydrochloride (1:1); ((2R,3R)-3-((S)-1-((3R,4S,5S)-4-((S)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoyl)-L-phenylalanine Hydrochloride. Grades: >98%. CAS No. 1415246-68-2. Molecular formula: C39H66ClN5O8. Mole weight: 768.42. | |
| MMAF intermediate 2 | MMAF intermediate 2 is an intermediate for the synthesis of MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent inhibitor of tubulin polymerization and the cytotoxic (ADC Cytotoxin) component of classic antibody drug conjugates (ADCs), such as Vorsetuzumab mafodotin and SGN-CD19A[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 864238-20-0. Pack Sizes: 25 mg; 50 mg; 100 mg. Product ID: HY-79254. | |
| MMAF-OMe | MMAF-Ome, an antitubulin agent, is also an ADC cytotoxin. MMAF-Ome inhibits several tumor cell lines with IC50s of 0.056 nM, 0.166 nM, 0.183 nM, and 0.449 nM for MDAMB435/5T4, MDAMB361DYT2, MDAMB468, and Raji (5T4-) cell lines, respectively. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Monomethyl auristatin F methyl ester. CAS No. 863971-12-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-79256. | |
| MMAF-OMe | MMAF-Ome is a methoxyl analogue of MMAF, used in antibody-drug conjugates (ADCs) as the antimitotic agent part. The methoxyl works as the reaction group. MMAF is a potent auristatin-derived antineoplastic agent, working by inhibition of tubulin polymerization. It exhibited cytotoxicity in Karpas 299, H3396, 786-O and Caki-1 cells with IC50 values of 119nM, 105nM, 257nM and 200nM after 96-hour treatment. Alternative Names: MMAF-OMe, Monomethyl auristatin F methyl ester; methyl (2S)-2-[[(2R,3R)-3-methoxy-3-[(2S)-1-[(3R,4S,5S)-3-methoxy-5-methyl-4-[methyl-[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(methylamino)butanoyl]amino]butanoyl]amino]heptanoyl]pyrrolidin-2-yl]-2-methylpropanoyl]amino]-3-phenylpropanoate. CAS No. 863971-12-4. Molecular formula: C40H67N5O8. Mole weight: 745.99. | |
| m,m'-Ditolylamine | m,m'-Ditolylamine. CAS No. 626-13-1. Molecular formula: C14H15N. Mole weight: 197.27g/mol. IUPAC Name: 3-methyl-N-(3-methylphenyl)aniline. SMILES: CC1=CC(=CC=C1)NC2=CC=CC(=C2)C. InChI: InChI=1S/C14H15N/c1-11-5-3-7-13(9-11)15-14-8-4-6-12(2)10-14/h3-10,15H,1-2H3. |  |
| m-Methoxytopolin | m-Methoxytopolin. Group: Biochemicals. Grades: Highly Purified. CAS No. 75737-39-2. Pack Sizes: 250mg, 500mg, 1g. Molecular Formula: C13H13N5O. US Biological Life Sciences. |  Worldwide |
| m-Methoxytopolin-9-glucoside | m-Methoxytopolin-9-glucoside is an intricate and potent bioactive compound, used for studying a myriad of afflictions including cancer, inflammation and neurodegenerative disorders. Alternative Names: 6-(3-Methoxybenzylamino)-9-b-D-glucopyranosylpurine. CAS No. 1226978-21-7. Molecular formula: C19H23N5O6. Mole weight: 417.42. | |
| m-Methoxytopolin riboside | It can be used in biological study in influence of plant growth regulators on shoot proliferation and secondary metabolite production in micropropagated Huernia hystrix. Alternative Names: N6-(m-Methoxybenzyl)adenosine; Mem-TR; 6-(3-Methoxybenzylamino)-9-b-D-ribofuranosylpurine; N6-(3-Methoxybenzyl)adenosine; N-(3-Methoxybenzyl)adenosine; (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((3-methoxybenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol; meta-Methoxytopolin Riboside; N-[(3-Methoxyphenyl)methyl]adenosine. Grades: ≥95%. CAS No. 101565-95-1. Molecular formula: C18H21N5O5. Mole weight: 387.39. | |
| m-Methyl Atomoxetine Hydrochloride | m-Methyl Atomoxetine Hydrochloride. Group: Biochemicals. Alternative Names: N-Methyl-γ - (3-methylphenoxy) benzenepropanamine Hydrochloride; Atomoxetine Related Compound B Hydrochloride. Grades: Highly Purified. CAS No. 873310-28-2. Pack Sizes: 2.5mg. Molecular Formula: C17H22ClNO, Molecular Weight: 291.82. US Biological Life Sciences. | Worldwide |
| M-METHYL BENZOYL CHLORIDE | M-METHYL BENZOYL CHLORIDE. CAS No. 1711-06-04. Product ID: ACM17110604. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| MMG-11 | MMG-11 is a potent and selective human TLR2 antagonist with low cytotoxicity. MMG-11 inhibits both TLR2/1 and TLR2/6 signaling with IC50s of 1.7?μM for Pam3CSK4-induced hTLR2/1 and 5.7?μM for Pam2CSK4-induced hTLR2/6 responses[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 313254-94-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-112146. | |
| MMGP1 | MMGP1 is an antifungal peptide which was found to possess potent antifungal activity against C. albicans. | |
| MMH2 | MMH2 is a novel BRD4 molecular glue degrader that functions by recruiting the CUL4 and DCAF16 ligases to the second bromodomain of BRD4 (BRD4BD2)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3079093-15-2. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-156828. | |
| MMI-0100 | MMI-0100 is a cell-permeant peptide inhibitor of mitogen activated protein kinase activated protein kinase II (MK2). MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. MMI-0100 suppresses IL-6 expression without effect on IL-8 expression. MMI-0100 suppresses fibrotic processes such as vein graft disease[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1039342-24-9. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-P3412. | |
| MMK1 | MMK1 is a potent and selective human formyl peptide receptor like-1 (FPRL-1/FPR2) agonist with EC50s of <2 nM and>10000 nM for FPRL-1 and FPR1, respectively. MMK1 is a potent chemotactic and calcium-mobilizing agonist. MMK1 potently activates phagocytic leukocytes and enhances Pertussis Toxin-sensitive production by human monocytes of proinflammatory cytokines IL-1b and IL-6. MMK1 exerts anxiolytic-like activity[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. CAS No. 271246-66-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P1117. | |
| MMK 1 | MMK 1. Group: Biochemicals. Grades: Purified. CAS No. 271246-66-3. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| MMK 1 | MMK 1 is a potent and selective human formyl peptide receptor FPR2 agonist (EC50 = 1, 2 and > 10 000 nM at mFRP2, hFPR2 and hFPR1 respectively). Some findings showed that the transient rise in intracellular free calcium induced by MMK-1 involves both a release of calcium from intracellular stores and an opening of channels in the plasma membrane. Alternative Names: MMK 1; MMK1; MMK-1; (4S)-4-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxy-3-methylsulfanylpropyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid. CAS No. 271246-66-3. Molecular formula: C75H123N19O18S. Mole weight: 1610.97. | |
| MMP13-IN-2 | MMP13-IN-2 is a potent, selective and orally active MMP-13 inhibitor. MMP13-IN-2 exhibits excellent potency for MMP-13 (IC50=0.036 nM) and selectivities (greater than 1,500-fold) over MMP-1, 3, 7, 8, 9, 14, and TACE. MMP13-IN-2 has the ability to block the release of collagen from cartilage in vitro. MMP13-IN-2 has the potential for collagenase related disease research[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 935759-55-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-122624. | |
| MMP-13 Inhibitor | MMP-13 Inhibitor is a potent and selective inhibitor of matrix metalloproteinase-13 (MMP-13) with IC50 value of 8 nM. Alternative Names: Collagenase-3 Inhibitor; Matrix Metalloproteinase-13 Inhibitor; 4,6-Pyrimidinedicarboxamide; N4,N6-Bis(4-fluoro-3-methylbenzyl)pyrimidine-4,6-dicarboxamide. Grades: ≥98%. CAS No. 544678-85-5. Molecular formula: C22H20F2N4O2. Mole weight: 410.4. | |
| MMP-1/MMP-9 Substrate, Fluorogenic | MMP-1/MMP-9 Substrate, Fluorogenic is a fluorogenic substrate for MMP-1 and MMP-9[1].Ex/Em = 340/440 nm. Uses: Scientific research. Category: Signaling pathways. CAS No. 150956-92-6. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P2179. | |
| MMP-2 Inhibitor I | MMP-2 Inhibitor I (OA-Hy) is a potent MMP-2 inhibitor with a Ki of 1.7 μM[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 10335-69-0. Pack Sizes: 1 mg; 5 mg. Product ID: HY-112546. | |
| MMP-2 Inhibitor I | MMP-2 Inhibitor I is a reversible inhibitor of matrix metalloproteinase 2 (MMP-2) with Ki value of 1.6 μM. It attenuates cancer cell migration via inhibition of MMP-2. Alternative Names: Matrix Metalloproteinase-2 Inhibitor I; cis-9-Octadecenoyl-N-hydroxylamide; Oleylhydroxamate; N-Hydroxyoleamide; OA-Hy; Oleoyl-N-hydroxylamide. Grades: ≥98%. CAS No. 10335-69-0. Molecular formula: C18H35NO2. Mole weight: 297.5. | |
| MMP-2 Inhibitor II | MMP-2 Inhibitor II (compound 2) is a selective MMP-2 inhibitor. The Kinetic parameters for MMP inhibition are 2.4 μM (MMP-2), 45 μM (MMP-1), and 379 μM (MMP-7), respectively[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 869577-51-5. Pack Sizes: 1 mg; 5 mg. Product ID: HY-130076. | |
| MMP-2/MMP-9-IN-1 | MMP-2/MMP-9-IN-1 is a highly selective, orally active and potent type IV collagenase (MMP-9 and MMP-2) inhibitor with IC50s of 0.24 and 0.31 μM for MMP-9 and MMP-2, respectively. MMP-2/MMP-9-IN-1 is orally active in animal models of tumor growth and metastasis. MMP-2/MMP-9-IN-1 can be used for the research of cancer[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 193807-58-8. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-116399. | |
| MMP-2/MMP-9 Inhibitor I | MMP-2/MMP-9 inhibitor I is a potent inhibitor of matrix metalloproteinase MMP-2/MMP-9 with IC50 values of 310 and 240 nM, respectively. It blocks MMP-2/MMP-9-dependent invasion, tumor growth, and metastasis in both cell culture and mouse tumor models. Alternative Names: Gelatinase A; N-([1,1'-biphenyl]-4-ylsulfonyl)-D-phenylalanine. Grades: 98%. CAS No. 193807-58-8. Molecular formula: C21H19NO4S. Mole weight: 381.44. | |
| MMP-2/MMP-9 Substrate | MMP-2/MMP-9 Substrate (Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt) is a synthetic chromogenic polypeptide substrate whose core structure mimics the cleavage sites of MMP-2 and MMP-9 (gelatinase A and B) in collagen. After being hydrolyzed by collagenase, MMP-2/MMP-9 Substrate reacts with 4,4'-dithiodipyridine or Ellman's Reagent via its thiol fragment to produce a product with ultraviolet absorption properties[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Ac-Pro-Leu-Gly-[(S)-2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OEt. CAS No. 99828-55-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P10143. | |
| MMP3 Antibody [N23A23] | MMP3,MMP-3. Group: Antibodies. Alternative Names: MMP3. Pack Sizes: 20ul. Product ID: F1042. Storage Conditions: -20°C (avoid freeze-thaw cycles), 2 years. | United States; Europe |
| MMP408 | MMP408 is a selective and orally effective inhibitor of MMP-12 with IC50 values for human, mouse and rat MMP-12 of 2 nM, 160 nM and 3 μM respectively. MMP408 exhibits IC50 value for human MMP-13 of 120 nM, and its activity against other MMPs is weak. MMP408 can alleviate inflammation, fibrosis and tissue remodeling by inhibiting MMP-12. MMP408 can be used in the research of chronic obstructive pulmonary disease and chronic sinusitis with nasal polyps[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1025716-81-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12093. | |
| MMP-7-IN-2 | MMP-7-IN-2 is a potent and selective inhibitor of MMP7 with an IC50 value of 16 nM. MMP-7-IN-2 can be used for the research of diseases such as cancer and fibrosis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2848717-49-5. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-153563. | |
| MMP-7-IN-3 | MMP-7-IN-3 is a potent and selective inhibitor of MMP-7. MMP-7-IN-3 suppresses kidney fibrosis progression in a mouse model with unilateral ureteral obstruction[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2865097-58-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg. Product ID: HY-156430. | |
| MMP-8 inhibitor-1 | MMP-8 inhibitor-1 (compound 21), a hydroxamic acid derivative, is a potent MMP-8 inhibitor without significant oral bioavailability[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MMP8-I. CAS No. 236403-25-1. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-128133. | |
| MMP9 Antibody [G4H21] | MMP9,MMP-9. Group: Antibodies. Alternative Names: MMP9. CAS No. Pack Sizes: 20ul. Product ID: F0008. Storage Conditions: -20°C (avoid freeze-thaw cycles), 2 years. | United States; Europe |
| MMP9 Antibody [P1J16] | MMP9,MMP-9. Group: Antibodies. Alternative Names: MMP9. CAS No. Pack Sizes: 20uL. Product ID: F2867. Storage Conditions: -20°C (avoid freeze-thaw cycles), 2 years. | United States; Europe |
| MMP-9-IN-1 | MMP-9-IN-1 is a specific matrix metalloproteinase-9 (MMP-9) inhibitor, which selectively target the hemopexin (PEX) domain of MMP-9, but not other MMPs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 502887-71-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-135232. | |
| MMP-9/MMP-13 Inhibitor I | MMP-9/MMP-13 Inhibitor I is a potent MMP-9 and MMP-13 inhibitor with IC50s of both 0.9 nM. MMP-9/MMP-13 Inhibitor I shows >20-folds selectivity for MMP-9/MMP-13 over other MMPs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 204140-01-2. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-128026. | |
| MMP Inhibitor II | MMP Inhibitor II (compound 4e) is a potent, reversible pan-MMP inhibitor with IC50 values of 24 nM, 18.4 nM, 30 nM, and 2.7 nM for MMP-1,MMP-3, MMP-7, and MMP-9, respectively[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 203915-59-7. Pack Sizes: 1 mg. Product ID: HY-119423. | |
| MMPIP hydrochloride | MMPIP hydrochloride. Group: Biochemicals. Grades: Purified. CAS No. 479077-02-6. Pack Sizes: 1mg, 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| MMPIP hydrochloride | MMPIP hydrochloride is an allosteric metabotropic glutamate receptor 7 (mGluR7) selective antagonist (KB values 24 -30 nM). MMPIP hydrochloride acts as a pharmacological tool for elucidating the roles of mGluR7 on central nervous system functions. MMPIP hydrochloride alleviates pain and normalizes affective and cognitive behavior in neuropathic mice[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1215566-78-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-103111. | |
| MMRi62 | MMRi62, a ferroptosis inducer targeting MDM2-MDM4 (negative regulators of tumor suppressor p53). MMRi62 shows a P53-independent pro-apoptotic activity against pancreatic ductal adenocarcinoma (PDAC) cells and induce autophagy. MMRi62 inducesferroptosis, resulting in a increase of reactive oxygen and lysosomal degradation of ferritin heavy chain (FTH1). MMRi62 also leads to proteasomal degradation of mutant p53, also inhibits orthotopic xenograft PDAC mouse model in vivo with high frequency mutation characteristics of KRAS and TP53.12[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 352693-80-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-148409. | |
| MMRi64 | MMRi64 disrupts Mdm2-MdmX interactions. MMRi64 downregulates Mdm2 and MdmX in leukemia cells. MMRi64 induces p53 accumulation, and induces the apoptotic arm of the p53 pathway in leukemia/lymphoma cells. MMRi64 can be used for cancer research[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 430458-66-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg. Product ID: HY-123950. | |
| MMTM | MMTM. Alternative Names: 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium tetrafluoroborate; MMTM; I14-3181; DMTMMT; SCHEMBL403227; KS-00000T9H; AK186617. Grades: 98%. CAS No. 293311-03-2. Molecular formula: C10H17N4O3BF4. Mole weight: 328.07. | |
| MMV009085 | MMV009085 is a potent PfHT1 (Plasmodium falciparum hexose transporter)-specific inhibitor and a potential anti-malarial agent. MMV009085 is also a human glucose transporter inhibitor, it has high potency in inhibiting both glucose uptake (IC50: 2.6 μM in glucose uptake assay) and growth of the parasites (EC50: 1.23±0.04 μM against 3D7)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 298217-59-1. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-153612. | |
| MMV019313 | MMV019313 is a potent, non-bisphosphonate inhibitor of farnesyl/geranylgeranyl diphosphate synthase (FPPS/GGPPS) with an IC50 of 0.82 μM. MMV019313 has activity against P. falciparum (Parasite)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 902630-14-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-113752. | |
| MMV030084 | MMV030084 is a potent PKG inhibitor that inhibits hepatocyte invasion by Plasmodium sporozoites, merozoite egress from asexual blood stage schizonts, and male gamete exflagellation. Alternative Names: MMV 030084; MMV-030084. Grades: >98%. CAS No. 342434-07-5. Molecular formula: C18H19ClN4O. Mole weight: 342.83. | |
| MMV688845 | MMV688845 is a nontuberculous mycobacteria (NTM) RNA polymerase inhibitor with bactericidal activity against Mycobacterium abscessus and anti-tuberculosis efficacy[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: (R)-GSK1729177A. CAS No. 2208962-35-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-148478. | |
| Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase | Requires Mn2+. Unlike EC 3.6.1.13, ADP-ribose diphosphatase, it cannot utilize Mg2+. ADP-D-ribose, CDP-choline, CDP-ethanolamine and ADP are substrates for this enzyme but ADP-D-glucose, UDP-D-glucose, CDP-D-glucose, CDP, CMP and AMP are not hydrolysed. In rat, the enzyme is found predominantly in thymus and spleen. Group: Enzymes. Synonyms: Mn2+-dependent ADP-ribose/CDP-alcohol pyrophosphatase; ADPRibase-Mn. Enzyme Commission Number: EC 3.6.1.53. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4625; Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase; EC 3.6.1.53; Mn2+-dependent ADP-ribose/CDP-alcohol pyrophosphatase; ADPRibase-Mn. Cat No: EXWM-4625. |  |
| Mn2O3 nanopowder | Mn2O3 nanopowder. Purity: 99.5 %. | |
| Mn3O4/graphene nanocomposite | Mn3O4/graphene nanocomposite. | |
| Mn3O4/reduced graphene oxide nanocomposite | Mn3O4/reduced graphene oxide nanocomposite. | |
| MN551 | MN551 is a potent inhibitor of cysteine-directed electrophilic covalent that plays important roles in the biology of SOCS2 and its CRL5 complex, and as E3 ligase handles in proteolysis targeting chimera (PROTACs) to induce targeted protein degradation[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3044099-90-0. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-156395. | |
| MN58b | MN58b is a selective choline kinase α (CHKα) inhibitor, and results in inhibition of phosphocholine synthesis. MN58b reduces cell growth through the induction of apoptosis, and also has antitumoral activity[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 203192-01-2. Pack Sizes: 1 mg. Product ID: HY-108431. | |
| MN 64 | MN 64. Group: Biochemicals. Grades: Purified. CAS No. 92831-11-3. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| MNI 137 | MNI 137. Group: Biochemicals. Grades: Purified. CAS No. 946619-21-2. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Mni caged kainic acid | Mni caged kainic acid. CAS No. 1315378-75-6. Product ID: ACM1315378756. Molecular formula: C19H23N3O6. Mole weight: 389.4. Alfa Chemistry - ISO 9001:32057 Certified. | |
| MNI-caged-L-glutamate | MNI-caged-L-glutamate is an inert photolabile glutamate precursor. MNI-caged-L-glutamate does not modulate NMDA and AMPA receptor function in cultured neurones. MNI-caged-L-glutamate can be used for research on neurotransmitters[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 295325-62-1. Pack Sizes: 1 mg; 5 mg. Product ID: HY-107520. | |
| MNI-caged-L-glutamate | MNI-caged-L-glutamate. Group: Biochemicals. Alternative Names: (αS)-Amino-2,3-dihydro-4-methoxy-7-nitro-δ-oxo-1H-indole-1-pentanoic Acid. Grades: Highly Purified. CAS No. 295325-62-1. Pack Sizes: 10mg. Molecular Formula: C14H17N3O6, Molecular Weight: 323.3. US Biological Life Sciences. | Worldwide |
| MNI-caged-L-glutamate-d3 | MNI-caged-L-glutamate-d3. Group: Biochemicals. Alternative Names: (αS)-Amino-2,3-dihydro-4-methoxy-7-nitro-δ-oxo-1H-indole-1-pentanoic Acid-d3. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C14H14D3N3O6, Molecular Weight: 326.32. US Biological Life Sciences. | Worldwide |
| Mn(II) protoporphyrin IX | Mn(II) protoporphyrin IX is a potential intravenous paramagnetic magnetic resonance contrast agent. Mn(II) protoporphyrin IX maintains strong paramagnetic properties[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 21393-64-6. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-136476A. | |
| Mn in-situ doped Ti3AlC2 MAX | Mn in-situ doped Ti3AlC2 MAX. CAS No. 196506-01-1. Purity: 0.99. | |
| Mniopetal A | Mniopetal A is a reverse transcriptase inhibitor produced by Mniopetalum sp. 87256. Alternative Names: 2-(Acetyloxy)decanoic acid, 4-formyl-3,3a,6,6a,7,8,9,10-octahydro-3,10-dihydroxy-7,7-dimethyl-1-oxo-1H-naptho(1,8-c)furan-yl ester. CAS No. 158760-98-6. Molecular formula: C27H40O9. Mole weight: 508.60. | |
| Mniopetal B | Mniopetal B is a reverse transcriptase inhibitor produced by Mniopetalum sp. 87256. Alternative Names: 2-Hydroxydecanoic acid, 4-formyl-3,3a,6,6a,7,8,9,10-octahydro-3,10-dihydroxy-7,7-dimethyl-1-oxo-1H-naptho(1,8-c)furan-9-yl ester. CAS No. 158760-99-7. Molecular formula: C25H38O8. Mole weight: 466.56. | |
Our database is helping our users find suppliers everyday.
